ray pharm limited
ray pharm limited Company Information
Company Number
06354157
Next Accounts
Apr 2025
Directors
Shareholders
addison business ltd
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
7/11 minerva road, park royal, london, NW10 6HJ
Website
-ray pharm limited Estimated Valuation
Pomanda estimates the enterprise value of RAY PHARM LIMITED at £2.7m based on a Turnover of £5.4m and 0.49x industry multiple (adjusted for size and gross margin).
ray pharm limited Estimated Valuation
Pomanda estimates the enterprise value of RAY PHARM LIMITED at £452k based on an EBITDA of £90.5k and a 4.99x industry multiple (adjusted for size and gross margin).
ray pharm limited Estimated Valuation
Pomanda estimates the enterprise value of RAY PHARM LIMITED at £0 based on Net Assets of £-83.1k and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ray Pharm Limited Overview
Ray Pharm Limited is a dissolved company that was located in london, NW10 6HJ with a Companies House number of 06354157. It operated in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in August 2007, it's largest shareholder was addison business ltd with a 100% stake. The last turnover for Ray Pharm Limited was estimated at £5.4m.
Upgrade for unlimited company reports & a free credit check
Ray Pharm Limited Health Check
Pomanda's financial health check has awarded Ray Pharm Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
3 Strong
4 Regular
4 Weak
Size
annual sales of £5.4m, make it smaller than the average company (£21.5m)
- Ray Pharm Limited
£21.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 21%, show it is growing at a faster rate (5%)
- Ray Pharm Limited
5% - Industry AVG
Production
with a gross margin of 26.8%, this company has a comparable cost of product (26.8%)
- Ray Pharm Limited
26.8% - Industry AVG
Profitability
an operating margin of 1.7% make it less profitable than the average company (3.6%)
- Ray Pharm Limited
3.6% - Industry AVG
Employees
with 10 employees, this is below the industry average (45)
- Ray Pharm Limited
45 - Industry AVG
Pay Structure
on an average salary of £61.5k, the company has an equivalent pay structure (£61.5k)
- Ray Pharm Limited
£61.5k - Industry AVG
Efficiency
resulting in sales per employee of £538.5k, this is equally as efficient (£582.1k)
- Ray Pharm Limited
£582.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Ray Pharm Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 93 days, this is slower than average (33 days)
- Ray Pharm Limited
33 days - Industry AVG
Stock Days
it holds stock equivalent to 52 days, this is in line with average (54 days)
- Ray Pharm Limited
54 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 15 weeks, this is more cash available to meet short term requirements (9 weeks)
15 weeks - Ray Pharm Limited
9 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 105.5%, this is a higher level of debt than the average (62.9%)
105.5% - Ray Pharm Limited
62.9% - Industry AVG
RAY PHARM LIMITED financials
Ray Pharm Limited's latest turnover from August 2018 is estimated at £5.4 million and the company has net assets of -£83.1 thousand. According to their latest financial statements, we estimate that Ray Pharm Limited has 10 employees and maintains cash reserves of £491.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||
| Other Income Or Grants | ||||||||||
| Cost Of Sales | ||||||||||
| Gross Profit | ||||||||||
| Admin Expenses | ||||||||||
| Operating Profit | ||||||||||
| Interest Payable | ||||||||||
| Interest Receivable | ||||||||||
| Pre-Tax Profit | ||||||||||
| Tax | ||||||||||
| Profit After Tax | ||||||||||
| Dividends Paid | ||||||||||
| Retained Profit | ||||||||||
| Employee Costs | ||||||||||
| Number Of Employees | ||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | ||||||||||
| Intangible Assets | ||||||||||
| Investments & Other | ||||||||||
| Debtors (Due After 1 year) | ||||||||||
| Total Fixed Assets | ||||||||||
| Stock & work in progress | 565,800 | |||||||||
| Trade Debtors | 66,761 | 2 | 2 | 2 | 2 | |||||
| Group Debtors | ||||||||||
| Misc Debtors | 463,861 | 431,570 | 66,761 | |||||||
| Cash | 491,507 | 1,095,879 | 1,224,474 | 629,356 | 619,050 | 1,247,743 | 1,330,903 | 594,723 | ||
| misc current assets | ||||||||||
| total current assets | 1,521,168 | 1,527,449 | 1,291,235 | 696,117 | 619,052 | 1,247,745 | 1,330,905 | 594,725 | ||
| total assets | 1,521,168 | 1,527,449 | 1,291,235 | 696,117 | 619,052 | 1,247,745 | 1,330,905 | 594,725 | ||
| Bank overdraft | ||||||||||
| Bank loan | ||||||||||
| Trade Creditors | 1,012,034 | 1,122,171 | 893,605 | 793,801 | 862,924 | 1,595,995 | 1,332,229 | 597,372 | ||
| Group/Directors Accounts | ||||||||||
| other short term finances | ||||||||||
| hp & lease commitments | ||||||||||
| other current liabilities | 592,232 | 566,497 | 404,751 | |||||||
| total current liabilities | 1,604,266 | 1,688,668 | 1,298,356 | 793,801 | 862,924 | 1,595,995 | 1,332,229 | 597,372 | ||
| loans | ||||||||||
| hp & lease commitments | ||||||||||
| Accruals and Deferred Income | ||||||||||
| other liabilities | ||||||||||
| provisions | ||||||||||
| total long term liabilities | ||||||||||
| total liabilities | 1,604,266 | 1,688,668 | 1,298,356 | 793,801 | 862,924 | 1,595,995 | 1,332,229 | 597,372 | ||
| net assets | -83,098 | -161,219 | -7,121 | -97,684 | -243,872 | -348,250 | -1,324 | -2,647 | ||
| total shareholders funds | -83,098 | -161,219 | -7,121 | -97,684 | -243,872 | -348,250 | -1,324 | -2,647 |
| Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | Aug 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | ||||||||||
| Depreciation | ||||||||||
| Amortisation | ||||||||||
| Tax | ||||||||||
| Stock | 565,800 | |||||||||
| Debtors | 32,291 | 364,809 | 66,759 | 2 | ||||||
| Creditors | -110,137 | 228,566 | 99,804 | -69,123 | -733,071 | 263,766 | 734,857 | 597,372 | ||
| Accruals and Deferred Income | 25,735 | 161,746 | 404,751 | |||||||
| Deferred Taxes & Provisions | ||||||||||
| Cash flow from operations | ||||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | ||||||||||
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | ||||||||||
| Group/Directors Accounts | ||||||||||
| Other Short Term Loans | ||||||||||
| Long term loans | ||||||||||
| Hire Purchase and Lease Commitments | ||||||||||
| other long term liabilities | ||||||||||
| share issue | ||||||||||
| interest | ||||||||||
| cash flow from financing | ||||||||||
| cash and cash equivalents | ||||||||||
| cash | -604,372 | -128,595 | 595,118 | 10,306 | -628,693 | -83,160 | 736,180 | 594,723 | ||
| overdraft | ||||||||||
| change in cash | -604,372 | -128,595 | 595,118 | 10,306 | -628,693 | -83,160 | 736,180 | 594,723 |
ray pharm limited Credit Report and Business Information
Ray Pharm Limited Competitor Analysis
Perform a competitor analysis for ray pharm limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other undefined companies, companies in NW10 area or any other competitors across 12 key performance metrics.
ray pharm limited Ownership
RAY PHARM LIMITED group structure
Ray Pharm Limited has no subsidiary companies.
Ultimate parent company
ADDISON BUSINESS LTD
#0057519
1 parent
RAY PHARM LIMITED
06354157
ray pharm limited directors
Ray Pharm Limited currently has 1 director, Mr Stylianos Stylianou serving since Apr 2012.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Stylianos Stylianou | Czech Republic | 45 years | Apr 2012 | - | Director |
P&L
August 2018turnover
5.4m
-43%
operating profit
90.5k
0%
gross margin
26.8%
+3.48%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2018net assets
-83.1k
-0.48%
total assets
1.5m
0%
cash
491.5k
-0.55%
net assets
Total assets minus all liabilities
ray pharm limited company details
company number
06354157
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
August 2007
age
18
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
August 2018
previous names
N/A
accountant
-
auditor
-
address
7/11 minerva road, park royal, london, NW10 6HJ
Bank
-
Legal Advisor
-
ray pharm limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ray pharm limited.
ray pharm limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for RAY PHARM LIMITED. This can take several minutes, an email will notify you when this has completed.
ray pharm limited Companies House Filings - See Documents
| date | description | view/download |
|---|
